UAE-Based TachyHealth Raises US$5 Million Series A To Expand Its AI Healthcare Solutions

UAE-based healthtech startup TachyHealth has raised US$5 million in a Series A funding round led by Saudi insurance company Tawuniya, with participation from several investors.  

Founded by Osama AbouElkhir, Mohamed Khadra, Amr Fawzy, and Ahmed Talaat in the US in 2018, the startup develops AI-powered healthcare technologies that enable payers and providers to deliver value-based care.  

In an interview with Inc. Arabia, AbouElkhir, co-founder and CEO of TachyHealth, said that the enterprise was born out of a shared belief that “healthcare could be smarter, fairer, and more sustainable if healthcare and artificial intelligence worked together.”  

“We'd all witnessed firsthand the inefficiencies draining the system and the misaligned incentives across different players," AbouElkhir said. "This was before the era of ChatGPT and large language models (LLMs) so not everyone knew what AI really could do if it [was put] to real work. We had this vivid vision back then, we believed that AI could be more than a buzzword, it could be a precision tool to improve quality of care and eliminate waste, estimated at over $100 billion annually in MENA alone."

That vision has since drawn strong backing from major industry players, including Saudi insurance giant Tawuniya, which led TachyHealth’s Series A round—a milestone AbouElkhir described as defining for the company. “Their participation validates not just our technology, but our vision for how AI can reshape healthcare systems," AbouElkhir noted. "We are very fortunate that our strategic investor understands the complexity of healthcare—they breathe it every day. We speak the same language.” 

AbouElkhir also noted that having a seasoned industry player like Tawuniya brings far more than capital. “That’s the beauty of having strategic investors, not only venture capitalists, on your cap table,” he said. “Their network unlocks introductions to the region, their insights improve our hyperlocal adaptation, and their strategic lens sharpens our roadmap.”

From its origins in the US, TachyHealth has now evolved into a multinational operation rooted in both innovation and regional impact. Headquartered in Delaware, TachyHealth today has established hubs in Riyadh, Dubai, and, more recently, Cairo. “This multi-hub model isn’t just logistics—it’s a strategic decision,” AbouElkhir said. “It gives us access to the US' talent pool and one of the most sophisticated technology innovations, while staying deeply embedded in the MENA region's healthcare space.” 

This regional footprint has allowed TachyHealth to work closely with healthcare organizations and insurers across the MENA. Its systems now process millions of transactions each month, supporting payers and providers in streamlining their daily operations. “We’ve never been seen as a technology vendor, but as a trusted partner for a long-term partnership,” AbouElkhir added. “Our focus has always been to transform how payers and providers interact across the region, helping them automate core processes, reduce waste, and improve outcomes.” 

At the center of TachyHealth’s innovation is its suite of AI-powered tools that make value-based healthcare more practical and measurable. These include AiReview, an intelligent claims auditing engine that processes claims with 95 percent accuracy and can handle 100,000 claims in under seven minutes; AiPharma, a decision-support solution designed to optimize pharmacy benefits in alignment with Saudi regulatory mandates; and AiCode, which applies AI and natural language processing to quickly convert doctors’ handwritten or dictated notes into precise codes as per the International Classification of Diseases, 10th Revision (ICD-10). 

“Together, these tools reduce human error, cut administrative time by 70–80 percent, and bring transparency to how healthcare decisions are made,” AbouElkhir explained. “Our clients report efficiency lifts and cost reductions with measurable improvements. The result is better alignment between payers and providers, and more time and resources devoted to actual patient care. That's what value-based healthcare really means for us: technology that serves people, not paperwork.” 

Building on that foundation, TachyHealth plans to channel its new funding toward scaling its AI healthcare systems and deepening collaboration between payers and providers to advance value-based care across the region. The investment will also fuel the development of Gazal, the company’s healthcare-focused large language model, and support the expansion of its team as well as its growth across Saudi Arabia, the UAE, and Egypt. “We are actually targeting 300 percent growth in the next 18 months,” AbouElkhir said. “We want to continue our exponential growth as we’ve been tripling since 2022 post the COVID-19 slowdown.” 

As TachyHealth thus enters a new phase of growth with new capital, AbouElkhir views its progress as part of a broader transformation unfolding across regional healthcare. “By 2027, we see TachyHealth powering this shift across the MENA,” AbouElkhir declared. “This [investment] round isn’t about a single win—it’s the launchpad for a $25 billion regional transformation, where payers, providers, and patients all thrive in smarter, fairer systems.” 

Drawing on his own fundraising experience, AbouElkhir said that building investor relationships in healthtech requires clarity and alignment rather than a focus on capital alone. According to him, founders should seek partners who share their vision, understand the complexity of their mission, and are genuinely invested in the long-term change the company aims to drive. “Be clear about your purpose,” AbouElkhir added. “Actually, healthcare is driven by purpose. Investors are drawn to conviction when you can explain not only what you're building but why it matters.” 

AbouElkhir also underscored the importance of trust and transparency in investor relations. “Treat due diligence as dialogue, not a defense thesis,” he said. “We gave prospects full access and ran pilots following the standard pitch. We bring them to our game—they see it to believe it. We’ve raised by being radically transparent and letting our technology speak for itself.” 

AbouElkhir also encouraged founders to lean on their own networks in the early stages. “Before our seed round, we reached out to our close network, people who trust us as founders, and know the scale of the problem we’re talking about," he said. "That warm meeting beats cold emails every time." Here, he pointed out that securing the right kind of backing can shape a company’s long-term success and direction. “Choose strategic partners who bring more than capital," AbouElkhir said. "Healthcare is not for everyone—it’s niche, and you must be selective. The right investor will challenge you, guide you, and open doors that money alone can’t.” 

Pictured in the lead image are TachyHealth co-founders Amr Fawzy, Osama AbouElkhir, Mohamed Khadra, and Ahmed Talaat. Image courtesy TachyHealth.